# Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis

> **NCT00542802** · PHASE3 · UNKNOWN · sponsor: **Scienze Neurologiche Ospedaliere** · enrollment: 630 (estimated)

## Conditions studied

- Epileptic Seizures
- Stroke

## Interventions

- **DRUG:** Levetiracetam
- **DRUG:** Carbamazepine

## Key facts

- **NCT ID:** NCT00542802
- **Lead sponsor:** Scienze Neurologiche Ospedaliere
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-09
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 630 (ESTIMATED)
- **Last updated:** 2008-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00542802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00542802, "Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00542802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*